Relapsing Polychondritis is a rare autoimmune disorder characterized by recurrent inflammation of cartilage throughout the body. Due to its rarity, the prevalence of Relapsing Polychondritis is not well-established. However, it is estimated to affect approximately 3.5 to 4.5 per million people. The condition can occur at any age, but it most commonly affects individuals between 40 and 60 years old. Relapsing Polychondritis can lead to significant morbidity and mortality if not properly managed, making early diagnosis and treatment crucial.
Relapsing Polychondritis (RP) is a rare autoimmune disease characterized by recurrent inflammation of cartilage throughout the body. Due to its rarity, the exact prevalence of RP is not well-established. However, it is estimated to affect approximately 3.5 to 4.5 per million people, making it a relatively uncommon condition.
RP can occur in individuals of any age, but it most commonly affects adults between the ages of 40 and 60. The disease can affect various cartilaginous structures, including the ears, nose, joints, and respiratory tract. Symptoms may include pain, swelling, redness, and deformity of the affected areas.
As an autoimmune disorder, RP occurs when the immune system mistakenly attacks healthy cartilage, leading to inflammation and damage. The exact cause of RP is unknown, and there is no cure for the disease. Treatment focuses on managing symptoms and preventing complications.
Due to the rarity of RP, it is crucial for individuals experiencing symptoms to consult with healthcare professionals for proper diagnosis and management.